LNA-T CNA CPG
CPG for incorporation of a locked nucleic acid T analogue at the 3' end of an oligonucleotide.
CPG for incorporation of a locked nucleic acid T analogue at the 3' end of an oligonucleotide.
Phosphoramidite used to incorporate an iodo-modified uridine internally or at the 5' end of an oligonucleotide.
Phosphoramidite for incorporation of a methyl-modified ribo-U ("ribo-T") in a synthetic oligonucleotide.
Monomer used to incorporate a T (U) nucleobase analogue in peptide nucleic acid synthesis.
Phosphoramidite used to incorporate a bromo-modified uridine internally or at the 5' end of an oligonucleotide.
Methoxy-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
POM-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
Phosphoramidite for incorporation of a locked nucleic acid T (U) analogue internally or at the 5' end of an oligonucleotide.
Phosphoramidite used to incorporate a 2'-OMe-U nucleobase when creating phosphorodithioate (PS2) linkages.
CPG column for incorporation of a 2'-O-methyl modified U nucleobase at the 3' end of an oligonucleotide.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |